Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus

Arthritis and Rheumatism

Volumn 58, Issue 2, 2008, Pages 541-546

  Niewold, Timothy B ^a,b   Rivera, Tania L ^c   Buyon, Jill P ^c   Crow, Mary K ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RO ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CELL ASSAY; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE CLASSIFICATION; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERVIEW; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; MATERNAL BLOOD; MATERNAL MORBIDITY; MEDICAL RECORD REVIEW; NEWBORN; NEWBORN DISEASE; NEWBORN LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; QUESTIONNAIRE; SCREENING; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; TELEPHONE;

ADULT; ANTIBODIES, ANTINUCLEAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INTERFERON TYPE I; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES; SJOGREN'S SYNDROME;

EID: 39749158486     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.23191     Document Type: Article

References (15)

1. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003;197:711-23.
2. Bave U, Nordmark G, Lovgren T, Ronnelid J, Cajander S, Eloranta ML, et al. Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism. Arthritis Rheum 2005;52:1185-95.
3. Kim T, Kanayama Y, Negoro N, Okamura M, Takeda T, Inoue T. Serum levels of interferons in patients with systemic lupus erythematosus. Clin Exp Immunol 1987;70:562-9.
4. Kirou KA, Lee C, George S, Louca K, Peterson MG, Crow MK. Activation of the interferon-α pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis Rheum 2005;52:1491-503.
5. Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, et al. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome [published erratum appears in Proc Natl Acad SCi USA 2006;103:5242], Proc Natl Acad Sci U S A 2006;103:2770-5.
6. Niewold TB, Hua J, Lehman TJ, Harley JB, Crow MK. High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus. Genes Immun 2007;8:492-502.
7. Lovgren T, Eloranta ML, Bave U, Alm GV, Ronnblom L. Induction of interferon-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum 2004;50:1861-72.
8. Buyon JP. Neonatal lupus syndromes. 4th ed. San Diego: Elsevier Academic Press; 2004.
9. Buyon JP, Hiebert R, Copel J, Craft J, Friedman D, Katholi M, et al. Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol 1998;31:1658-66.
10. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, and the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
11. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
12. Hua J, Kirou K, Lee C, Crow MK. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies. Arthritis Rheum 2006;54:1906-16.
13. Kirou KA, Lee C, George S, Louca K, Papagiannis IG, Peterson MG, et al. Coordinate overexpression of interferon-α-induced genes in systemic lupus erythematosus. Arthritis Rheum 2004;50:3958-67.
14. Mavragani CP, Niewold TB, Moutsopoulos NM, Pillemer SR, Wahl SM, Crow MK. Augmented interferon-α pathway activation in patients with Sjögren's syndrome treated with etanercept. Arthritis Rheum 2007;56:3995-4005.
15. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007;8:487-96.